1.
Clin J Am Soc Nephrol
; 16(2): 284-286, 2021 02 08.
Article
in English
| MEDLINE
| ID: mdl-32948642
Subject(s)
Acute Kidney Injury/epidemiology , COVID-19/epidemiology , Academic Medical Centers , Acute Kidney Injury/diagnosis , Acute Kidney Injury/mortality , Acute Kidney Injury/therapy , Aged , COVID-19/diagnosis , COVID-19/mortality , COVID-19/therapy , Female , Hospital Mortality , Hospitalization , Hospitals, Urban , Humans , Incidence , Kidney Function Tests , Male , Middle Aged , New York City/epidemiology , Recovery of Function , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome
2.
Prim Care
; 47(4): 615-629, 2020 Dec.
Article
in English
| MEDLINE
| ID: mdl-33121632
ABSTRACT
Nephritic syndrome is a constellation of hematuria, proteinuria, hypertension, and in some cases acute kidney injury and fluid retention characteristic of acute glomerulonephritis. Infection-related glomerulonephritis, IgA nephropathy, lupus nephritis, membranoproliferative glomerulonephritis, and antineutrophil cytoplasmic antibody-associated vasculitis are the most common diseases in nephritic syndrome that primary care physicians might encounter in practice such that a solid comprehension of these can lead to earlier detection. This article describes the pathophysiology, incidence, clinical presentation, treatment, and disease progression of these nephritic syndrome entities, and provides guidance for when to refer to a nephrologist.
Subject(s)
Glomerulonephritis/physiopathology , Nephrotic Syndrome/physiopathology , Age Factors , Biomarkers , Glomerulonephritis/diagnosis , Hematuria , Humans , Nephrotic Syndrome/diagnosis , Primary Health Care , Referral and Consultation , Risk Factors , Sex Factors
3.
Clin J Am Soc Nephrol
; 16(1): 124-126, 2020 12 31.
Article
in English
| MEDLINE
| ID: mdl-32943397
Subject(s)
Acute Kidney Injury/therapy , Anticoagulants/therapeutic use , COVID-19/complications , Continuous Renal Replacement Therapy/instrumentation , Equipment Failure/statistics & numerical data , Acute Kidney Injury/virology , Aged , Arginine/analogs & derivatives , Arginine/therapeutic use , Citric Acid/therapeutic use , Disposable Equipment , Female , Heparin, Low-Molecular-Weight/therapeutic use , Humans , Male , Middle Aged , Pipecolic Acids/therapeutic use , SARS-CoV-2 , Sulfonamides/therapeutic use , Time Factors
4.